Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Biphosphonate and Jaws Osteonecrosis. Considerations About of Treatment
Author: Jaimes, M
Netto, HDDMC
Olate, S
Chaves, MDAM
Barbosa, JRDA
Abstract: Bisphosphonates are strong osteoclastic inhibitor activities, being these drugs usually for treatment of multiple myeloma and bone metastases of solid tumors like breast cancer. The osteonecrosis of the maxillary bones was first described in 2003. The relation of these medicines and maxillary bone osteonecrosis still uncertain. The incidence of this bone necrosis was very low before biphosphonates using. Nowadays this complication reach at least 10% of patients in these therapy using. The present work mean to alert for possible complication in biphosphonates using patients, thru a literature review and a clinical case presentation.
Subject: Bisphosphonate
bony metastasis
Country: Chile
Editor: Soc Chilena Anatomia
Rights: fechado
Date Issue: 2008
Appears in Collections:Artigos e Materiais de Revistas Científicas - Unicamp

Files in This Item:
File Description SizeFormat 
WOS000265411500028.pdf539.4 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.